The Effect of DA-6034 on Intestinal Permeability in an Indomethacin- Induced Small Intestinal Injury Model
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: DA-6034 has anti-inflammatory activities and exhibits cytoprotective effects in acute gastric injury models. However, explanations for the protective effects of DA-6034 on intestinal permeability are limited. This study sought to investigate the effect of DA-6034 on intestinal permeability in an indomethacin-induced small intestinal injury model and its protective effect against small intestinal injury. Methods: Rats in the treatment group received DA-6034 from days 0 to 2 and indomethacin from days 1 to 2. Rats in the control group received indomethacin from days 1 to 2. On the fourth day, the small intestines were examined to compare the severity of inflammation. Intestinal permeability was evaluated by using fluorescein isothiocyanate-labeled dextran. Western blotting was performed to confirm the association between DA-6034 and the extracellular signal-regulated kinase (ERK) pathway. Results: The inflammation scores in the treatment group were lower than those in the control group, but the difference was statistically insignificant. Hemorrhagic lesions in the treatment group were broader than those in the control group, but the difference was statistically insignificant. Intestinal permeability was lower in the treatment group than in the control group. DA-6034 enhanced extracellular signal-regulated kinase expression, and intestinal permeability was negatively correlated with ERK expression. Conclusions: DA-6034 may decrease intestinal permeability in an indomethacin-induced intestinal injury model via the ERK pathway.
Abstract
Background/Aims: DA-6034 has anti-inflammatory activities and exhibits cytoprotective effects in acute gastric injury models. However, explanations for the protective effects of DA-6034 on intestinal permeability are limited. This study sought to investigate the effect of DA-6034 on intestinal permeability in an indomethacin-induced small intestinal injury model and its protective effect against small intestinal injury. Methods: Rats in the treatment group received DA-6034 from days 0 to 2 and indomethacin from days 1 to 2. Rats in the control group received indomethacin from days 1 to 2. On the fourth day, the small intestines were examined to compare the severity of inflammation. Intestinal permeability was evaluated by using fluorescein isothiocyanate-labeled dextran. Western blotting was performed to confirm the association between DA-6034 and the extracellular signal-regulated kinase (ERK) pathway. Results: The inflammation scores in the treatment group were lower than those in the control group, but the difference was statistically insignificant. Hemorrhagic lesions in the treatment group were broader than those in the control group, but the difference was statistically insignificant. Intestinal permeability was lower in the treatment group than in the control group. DA-6034 enhanced extracellular signal-regulated kinase expression, and intestinal permeability was negatively correlated with ERK expression. Conclusions: DA-6034 may decrease intestinal permeability in an indomethacin-induced intestinal injury model via the ERK pathway.
참고문헌 (20)
- Barbara G, "Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome", J Clin Gastroenterol, 46, pp.S52~S55 (2012)
- Gecse K, "Leaky gut in patients with diarrheapredominant irritable bowel syndrome and inactive ulcerative colitis", Digestion, 85, pp.40~46 (2012)
- Suenaert P, "Anti-tumor necrosis factor treatment restores the gut barrier in Crohn’s disease", Am J Gastroenterol, 97, pp.2000~2004 (2002)
- Thiéfin G, "Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel, colon, and rectum", Joint Bone Spine, 72, pp.286~294 (2005)
- Sandek A, "The emerging role of the gut in chronic heart failure", Curr Opin Clin Nutr Metab Care, 11, pp.632~639 (2008)
- Ilan Y, "Leaky gut and the liver: a role for bacterial translocation in nonalcoholic steatohepatitis", World J Gastroenterol, 18, pp.2609~2618 (2012)
- Boroni Moreira AP, "Gut microbiota and the development of obesity", Nutr Hosp, 27, pp.1408~1414 (2012)
- Caricilli AM, "The role of gut microbiota on insulin resistance", Nutrients, 5, pp.829~851 (2013)
- Diao L, "Rebamipide suppresses diclofenacinduced intestinal permeability via mitochondrial protection in mice", World J Gastroenterol, 18, pp.1059~1066 (2012)
- Pozzoli C, "Protective effects of proton pump inhibitors against indomethacin-induced lesions in the rat small intestine", Naunyn Schmiedebergs Arch Pharmacol, 374, pp.283~291 (2007)
- Ukena SN, "Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity", PLoS One, 2, pp.e1308~ (2007)
- Kim JW, "The effects of DA-6034 on NFkappaB activity induced by lipopolysaccharide or tumor necrosis factor alpha in a human colonic epithelial cell line", Hepatogastroenterology, 55, pp.2059~2064 (2008)
- Nam SY, "DA-6034, a derivative of flavonoid, prevents and ameliorates dextran sulfate sodium-induced colitis and inhibits colon carcinogenesis", Exp Biol Med (Maywood), 233, pp.180~191 (2008)
- Garg P, "Selective ablation of matrix metalloproteinase-2 exacerbates experimental colitis: contrasting role of gelatinases in the pathogenesis of colitis", J Immunol, 177, pp.4103~4112 (2006)
- Chiu CJ, "Intestinal mucosal lesion in low-flow states: I. a morphological, hemodynamic, and metabolic reappraisal", Arch Surg, 101, pp.478~483 (1970)
- Miki K, "The sugar permeability test reflects disease activity in children and adolescents with inflammatory bowel disease", J Pediatr, 133, pp.750~754 (1998)
- Kato S, "Dual role of serotonin in the pathogenesis of indomethacin-induced small intestinal ulceration:pro-ulcerogenic action via 5-HT3 receptors and anti-ulcerogenic action via 5-HT4 receptors", Pharmacol Res, 66, pp.226~234 (2012)
- Engelman JA, "Targeting PI3K signalling in cancer: opportunities, challenges and limitations", Nat Rev Cancer, 9, pp.550~562 (2009)
- Suzuki H, "Lansoprazole promotes gastric mucosal cell proliferation and migration by activating p44", p42 mitogen-activated protein kinase, 2004, pp.12, 93~99
- 이성희, "Intestinal Permeability Regulation by Tight Junction: Implication on Inflammatory Bowel Diseases", Intestinal research, 13(1), pp.11~18 (2015), 대한장연구학회[DOI]